Immune Pharmaceuticals Will Request an Appeal to Regain...

2017-01-13T10:42:14-08:00

NEW YORK, Jan. 9, 2017 /PRNewswire/ — Immune Pharmaceuticals Inc. (Nasdaq: IMNP) (“Immune”), announced today that it intends to request a hearing before the Nasdaq Listing Qualifications Staff Panel to ...